Andrea Facciabene

6.0k citations
57 papers · 3.8k indexed · 2 hit papers · h-index 25
Topics
Cancer Immunotherapy and Biomarkers (22 papers)Immunotherapy and Immune Responses (21 papers)CAR-T cell therapy research (12 papers)
Partner nations
United StatesItalyGreece

In The Last Decade

Andrea Facciabene

55 papers receiving 3.8k citations

Hit Papers

Tumour hypoxia promotes tolerance and angiogenesis via CC...2011202620162021201120122505007501000

Peers

Andrea Facciabene
Comparison fields: 5 of 111
  • Immunology 2.0k
  • Oncology 2.0k
  • Molecular Biology 1.4k
  • Cancer Research 562
  • Pulmonary and Respiratory Medicine 351
Replace Wojciech Szeliga with:
Wojciech Szeliga United States
Zvi Granot Israel
Djordje Atanackovic Germany
Viktor Umansky Germany
Jitka Fučíková Czechia
Damya Laoui Belgium
Masahisa Jinushi Japan
Stefano Ugel Italy
Vinit Kumar United States
Susanna Mandruzzato Italy
Andrea Facciabene relative to Wojciech Szeliga United States Wojciech Szeliga's profile →
Citations per field
00.5×1.5×
Wojciech Szeliga · 1×
Citations per year

Countries citing papers authored by Andrea Facciabene

Since Specialization
Citations

This map shows the geographic impact of Andrea Facciabene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Facciabene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Facciabene more than expected).

Fields of papers citing papers by Andrea Facciabene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Facciabene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Facciabene. The network helps show where Andrea Facciabene may publish in the future.

Co-authorship network of co-authors of Andrea Facciabene

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Facciabene. A scholar is included among the top collaborators of Andrea Facciabene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Facciabene. Andrea Facciabene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 4
3 3
4 4
5 19
6 96
7 93
8 106
9 29
10 24
11 13
12
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cellsbreakdown →
1094
13 44
14 35
15 25
16 101
17 430
18 32
19 60
20 3

About Andrea Facciabene

Andrea Facciabene is a scholar working on Immunology, Oncology and Biotechnology, having authored 57 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Immunotherapy and Immune Responses (21 papers) and CAR-T cell therapy research (12 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (2.0k citations) and Cancer Research (562 citations). Andrea Facciabene has collaborated with scholars based in United States, Italy and Greece. Frequent co-authors include George Coukos, Gregory T. Motz, Phyllis A. Gimotty, Klara Balint, Xiaohui Peng, C. Blake Gilks, Ian S. Hagemann, Andrea Barchetti, Liping Wang and Lin Zhang. Their work appears in journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026